1. |
Nan H, Pang Z, Wang S, et al. Serum uric acid, plasma glucose and diabetes[J]. Diab Vasc Dis Res, 2010, 7(1): 40-46.
|
2. |
Yuan HJ, Yang XG, Shi XY, et al. Association of serum uric acid with different levels of glucose and related factors[J]. Chin Med J, 2011, 124(10): 1443-1448.
|
3. |
Heinig M, Johnson RJ. Role of uric acid in hypertension, renal disease, and metabolic syndrome[J]. Cleve Clin J Med, 2006, 73(12): 1059-1064.
|
4. |
Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010, 362(12): 1090-1101.
|
5. |
Wareham NJ, Phillips DI, Byrne CD, et al. The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion[J]. Diabet Med, 1995, 12(10): 931.
|
6. |
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp[J]. Diabetes Care, 1999, 22(9): 1462-1470.
|
7. |
Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans[J]. Diabetes, 1995, 44(12): 1386-1391.
|
8. |
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling[J]. Diabetes Care, 2004, 27(6): 1487-1495.
|
9. |
Aloulou I, Brun JF, Mercier J. Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with the minimal model analysis of an intravenous glucose tolerance test[J]. Metabolism, 2006, 55(5): 676-690.
|
10. |
Kadowaki T, Miyake Y, Hagura R, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance[J]. Diabetologia, 1984, 26(1): 44-49.
|
11. |
Utzschneider KM, Prigeon RL, Faulenbach MV, et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels[J]. Diabetes Care, 2009, 32(2): 335-341.
|
12. |
Meshkani R, Zargari M, Larijani B. The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects[J]. Acta Diabetol, 2011, 48(1): 79-88.
|
13. |
Lorenzo C, Hazuda HP, Haffner SM. Insulin resistance and excess risk of diabetes in Mexican-Americans: the san antonio heart study[J]. J Clin Endocrinol Metab, 2012, 97(3): 793-799.
|
14. |
Yang T, Chu CH, Bai CH, et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study[J]. Atherosclerosis, 2012, 220(2): 525-531.
|
15. |
Rodrigues SL, Baldo MP, Capingana P, et al. Gender distribution of serum uric acid and cardiovascular risk factors: population based study[J]. Arq Bras Cardiol, 2012, 98(1): 13-21.
|
16. |
Stancáková A, Javorský M, Kuulasmaa T, et al. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6 414 Finnish men[J]. Diabetes, 2009, 58(5): 1212-1221.
|
17. |
Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function[J]. Diabetes, 1993, 42(11): 1663-1672.
|